Table 2. MFGS-gc transduction of... | American Society of Hematology

Table 2.

MFGS-gc transduction of X-linked severe combined immunodeficiency B-cell lines

XSCID phenotype	N^*	Appearance or increase (%) of γ_c on cells after transduction with MFGS-gc with envelope^†			Geometric mean channel increase^‡
XSCID phenotype	N^*	Amphotropic	GALV	RD114	Amphotropic	GALV	RD114
γ $_{c}^{-}$ (Pt 1, 2)	4	14 ± 9	17 ± 9	39 ± 16	167 ± 46	179 ± 42	209 ± 37
γ $_{c}^{+}$ (Pt 3)	2	2 ± 1	0 ± 0	13 ± 16	41 ± 58	50 ± 51	114 ± 13

XSCID phenotype	N^*	Appearance or increase (%) of γ_c on cells after transduction with MFGS-gc with envelope^†			Geometric mean channel increase^‡
XSCID phenotype	N^*	Amphotropic	GALV	RD114	Amphotropic	GALV	RD114
γ $_{c}^{-}$ (Pt 1, 2)	4	14 ± 9	17 ± 9	39 ± 16	167 ± 46	179 ± 42	209 ± 37
γ $_{c}^{+}$ (Pt 3)	2	2 ± 1	0 ± 0	13 ± 16	41 ± 58	50 ± 51	114 ± 13

XSCID indicates X-linked severe combined immunodeficiency; GALV, gibbon ape leukemia virus; Pt, patient.

Number of experiments.

Mean ± SD of increase in proportion of γ $_{c}^{+}$ cells.

Mean ± SD of increase of mean fluorescence channel of γ $_{c}^{+}$ cells.